SIMEPREVIR AND SOFOSBUVIR WITH OR WITHOUT RIBAVIRIN IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS: EFFICACY AND SAFETY IN REAL LIFE

被引：1
|
作者：
Ramos, H. [1 ]
Gomez, J. [1 ]
Linares, P. [2 ]
Martin, I. [3 ]
Almohalla, C. [4 ]
Jorquera, F. [2 ]
Garcia, I. [5 ]
Vasquez, M. [6 ]
Conde, P. [7 ]
Badia, E. [1 ]
Alvarez, B. [2 ]
Karpman, G. [8 ]
Lorenzo, S. [9 ]
Gozalo, V.
Joao, D. [2 ]
de Benito, M. [4 ]
Ruiz, L. [9 ]
Jimenez, F. [3 ]
Saez-Rouela, F. [1 ]
机构：
[1] Hosp Univ Burgos, Gastroenterol & Hepatol, Burgos, Spain
[2] Complejo Asistencial Univ Leon, Gastroenterol & Hepatol, Leon, Spain
[3] Hosp Univ Salamanca, Gastroenterol & Hepatol, Salamanca, Spain
[4] Hosp Univ Rio Hortega, Hepatol, Valladolid, Spain
[5] Complejo Asistencial Palencia, Gastroenterol & Hepatol, Palencia, Spain
[6] Hosp Santos Reyes, Gastroenterol & Hepatol, Aranda De Duero, Spain
[7] Complejo Asistencial Zamora, Gastroenterol & Hepatol, Zamora, Spain
[8] Hosp El Bierzo, Gastroenterol & Hepatol, Ponferrada, Spain
[9] Hosp Clin Univ Valladolid, Gastroenterol & Hepatol, Valladolid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)01492-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT-152
引用
收藏
页码：S765 / S766
页数：2
相关论文
共 50 条
  • [1] Safety and efficacy of simeprevir plus sofosbuvir with or without ribavirin in patients with decompensated genotype 1 hepatitis C cirrhosis
    Modi, Apurva A.
    Nazario, Hector
    Trotter, James F.
    Gautam, Manjushree
    Weinstein, Jeffrey
    Mantry, Parvez
    Barnes, Maisha
    Habib, Adil
    McAfee, Jean
    Teachenor, Olga
    Tujague, Lauren
    Gonzalez, Stevan
    [J]. LIVER TRANSPLANTATION, 2016, 22 (03) : 281 - 286
  • [2] Sofosbuvir in combination with ribavirin or simeprevir: real-life study of patients with hepatitis C genotype 4
    Abdel-Moneim, Adel
    Aboud, Alaa
    Abdel-Gabbar, Mohamed
    Zanaty, Mohamed I.
    Abd Elbary, Amr A.
    Ramadan, Mohamed
    [J]. ANNALS OF GASTROENTEROLOGY, 2019, 32 (01): : 93 - +
  • [3] Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4
    Adel Abdel-Moneim
    Alaa Aboud
    Mohamed Abdel-Gabaar
    Mohamed I. Zanaty
    Mohamed Ramadan
    [J]. Hepatology International, 2018, 12 : 348 - 355
  • [4] Efficacy and safety of sofosbuvir plus daclatasvir with or without ribavirin: large real-life results of patients with chronic hepatitis C genotype 4
    Abdel-Moneim, Adel
    Aboud, Alaa
    Abdel-Gabaar, Mohamed
    Zanaty, Mohamed I.
    Ramadan, Mohamed
    [J]. HEPATOLOGY INTERNATIONAL, 2018, 12 (04) : 348 - 355
  • [5] Safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in hepatitis C genotype 1 patients including those with decompensated cirrhosis who failed prior treatment with simeprevir/sofosbuvir
    Modi, A. A.
    Nazario, H. E.
    Gonzales, G. R.
    Gonzalez, S. A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (10) : 1409 - 1415
  • [6] Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis
    Aqel, Bashar A.
    Pungpapong, Surakit
    Leise, Michael
    Werner, K. Tuesday
    Chervenak, Amy E.
    Watt, Kymberly D.
    Murphy, Jennifer L.
    Ryland, Kristen
    Keaveny, Andrew P.
    McLemore, Ryan
    Vargas, Hugo E.
    [J]. HEPATOLOGY, 2015, 62 (04) : 1004 - 1012
  • [7] Efficacy and Safety of Sofosbuvir Plus Ribavirin Treatment for Patients with Chronic Hepatitis C Genotype 2
    Sugimoto, Kayo
    Kim, Soo Ki
    Kim, Soo Ryang
    Kobayashi, Mana
    Kato, Airi
    Morimoto, Eri
    Imoto, Susumu
    Kim, Chi Wan
    Tanaka, Yasuhito
    Kudo, Masatoshi
    Yano, Yoshihiko
    Hayashi, Yoshitake
    [J]. DIGESTIVE DISEASES, 2016, 34 (06) : 627 - 631
  • [8] Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study
    Pellicelli, Adriano M.
    Palitti, Valeria Pace
    Vignally, Pascal
    Ceccherini-Silberstein, Francesca
    Siciliano, Massimo
    Giannelli, Valerio
    Moretti, Alessandra
    Tarquini, Pierluigi
    Scifo, Gaetano
    Messina, Vincenzo
    Ascione, Antonio
    Izzi, Antonio
    Marignani, Massimo
    D'Ambrosio, Cecilia
    Fondacaro, Lucia
    Ettorre, Giuseppe M.
    Ialongo, Pasquale
    Sacco, Rodolfo
    Perno, Carlo F.
    Barbarini, Giorgio
    [J]. LIVER INTERNATIONAL, 2017, 37 (05) : 653 - 661
  • [9] Safety and efficacy of Simeprevir plus Sofosobuvir with or without Ribavirin in Patients with Decompensated Genotype 1 Hepatitis C induced Cirrhosis
    Modi, Apurva A.
    Nazario, Hector
    Gonzalez, Stevan A.
    Gautam, Manjushree
    Weinstein, Jeffrey S.
    Mantry, Parvez S.
    Barnes, Maisha
    Habib, Adil
    McAfee, Jean L.
    Teachenor, Olga
    Tujague, Lauren
    Trotter, James F.
    [J]. HEPATOLOGY, 2014, 60 : 661A - 661A
  • [10] Safety and Efficacy of Sofosbuvir with Simeprevir with or without Ribavirin for Hepatitis C Genotype 1 with Severe Renal Impairment: A Meta-Analysis of Cohort Studies
    Singhal, Ruchi
    Tiwari, Pramil
    Duseja, Ajay
    Ahlawat, Rajiv
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 549 - 550
12345